Crossmark

Tamoxifen mechanically reprograms the tumor microenvironment via <scp>HIF</scp> ‐1A and reduces cancer cell survival

Crossref DOI link: https://doi.org/10.15252/embr.201846557

Published Online: 2018-12-12

Published Print: 2019-01

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Cortes, Ernesto

Lachowski, Dariusz https://orcid.org/0000-0003-1194-8019
Robinson, Benjamin

Sarper, Muge

Teppo, Jaakko S https://orcid.org/0000-0003-1022-5572
Thorpe, Stephen D

Lieberthal, Tyler J

Iwamoto, Kazunari

Lee, David A https://orcid.org/0000-0001-7646-4643
Okada‐Hatakeyama, Mariko

Varjosalo, Markku T

del Río Hernández, Armando E https://orcid.org/0000-0001-5062-8910
Funding

Funding for this research was provided by:

FP7 Ideas: European Research Council (282051)

Osaka University (ICRa‐17‐01)

Japan Society for the Promotion of Science (15KT0084)

Japan Agency for Medical Research and Development

Nagase Science Technology Foundation

Astellas Foundation for Research on Metabolic Disorders

Biotechnology and Biological Sciences Research Council (BB/N018532/1)
License Information

Version of Record valid from 2018-12-12
More Information

Publication History

Received: 2018-06-09

Accepted: 2018-10-23

Published: 2018-12-12